Iridex Corp revenue by segment IRIX

Annual Quarterly

Iridex Corp splits its revenue into 4 lines in its filings. The largest line in fiscal 2026, which ended Jan 3, 2026 was Retina at $30.3 million, 57% of the total.

USD in millions. The percent under a figure is the change from the year before.

Line	FY 2026 Jul 4, 2026	FY 2026 Jan 3, 2026	FY 2024 Dec 28, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 31, 2022	FY 2021 Jan 1, 2022	FY 2021 Jan 2, 2021	FY 2019 Dec 28, 2019	FY 2018 Dec 29, 2018	FY 2017 Dec 30, 2017	FY 2016 Dec 31, 2016
Revenue	—	53	49	52	57	54	36	43	43	42	46
Retina	—	30 share 57.5%	28 -5.5% share 57.2%	29 -7.0% share 56.8%	32 share 55.6%	31 share 57.7%	—	—	—	—	—
Cyclo G Six	—	14 share 26.3%	13 -5.7% share 26.1%	13 -8.4% share 26.0%	15 share 25.8%	14 share 25.9%	—	—	—	—	—
Product And Service Other	—	9 share 16.2%	8 -9.1% share 16.7%	9 -15.6% share 17.3%	11 share 18.6%	9 share 16.4%	—	—	—	—	—
Services	—	0 share 0.0%	0 -99.9% share 0.0%	2 +1.7% share 3.0%	2 share 2.6%	1 share 2.6%	—	—	—	—	—

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as: IRIX (Nasdaq)
Fiscal year ends: January 3
Incorporated in: DE
Headquarters: Mountain View, CA
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 1006045

Other Electromedical & Electrotherapeutic Apparatus companies

All 31 Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.